The Science Insdide

Redefining The Capabilities of Foam With Open Cell Foam

On-Demand Webinar

With: Avi Robbins
Vice President of Global Product Development and R&D, Porex

Why watch this on-demand webinar

Gone are the days of foam simply operating as foam. New advancements in material development allow the infusion of customer-exclusive additives including antimicrobials, nanomaterials, pharmaceuticals, botanicals, cosmetic ingredients and colorants – thereby helping to achieve custom product specifications and to enhance product differentiation. In addition to the ability to implement unique formulas and ingredients, the open-cell foam structure allows for premium design flexibility, including a wide array of densities, pore volumes, and textures.

Whether your innovation is for medical applications and requires superior absorption and medical-grade (ISO 10993) certification or for the cosmetics industry and needs exceptional softness, open-cell foams can yield consistent product performance and enhance the end-user experience.

In this webinar, challenge what you know about foam and discover the unique manufacturing process of open-cell foam and how to determine the material and characteristics your product design needs.

Hosted By:

Avi Robins

Vice President of Global Product Development and R&D

Avi Robbins is the Vice President of Global Product Development and R&D. He joined POREX in 2010. Mr. Robbins has an array of technical and commercial experience in a variety of material and manufacturing technologies as well as markets globally. He was previously with Facet Technologies, an Atlanta based Medical Device Design and Manufacturing company focusing in the diabetes space holding a variety of positions such as R&D Management, Operations Engineering Management, and Program Management. Mr. Robbins has his Bachelor’s and Master’s Degree in Mechanical Engineering from Georgia Institute of Technology as well as a Master’s Degree in Business (MBA) from Emory University.

Register and the link to the on-demand webinar will be sent to you